Evidence map›Paper›PMID 1833409›Full record

ArticleThe Journal of cell biology1991

Ankyrin binds to the 15th repetitive unit of erythroid and nonerythroid beta-spectrin.

S P Kennedy, S L Warren, B G Forget, J S Morrow

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 170 citations in OpenAlex.

  1. Trafficking mechanisms underlying NaChannels (Austin, Tex.) · 2020
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. βIV-Spectrin and CaMKII facilitate Kir6.2 regulation in pancreatic beta cells.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  11. Article
  12. Article
  13. β-III spectrin is critical for development of purkinje cell dendritic tree and spine morphogenesis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Do we already know how spectrin attracts ankyrin?Cellular and molecular life sciences : CMLS · 2010
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

S P KennedyDepartment of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510.
S L Warren
B G Forget
J S Morrow
Yale University · US

Funding

MEMBRANE SKELETAL CONTROL IN HEMOLYTIC DISORDERSR01HL028560 · NHLBI · YALE UNIVERSITY · PI MORROW, JON S · 1985 to 2011
$3.3M
EPITHELIAL CELL POLARITY: SPECTRIN-ANKYRIN INTERACTIONSF32DK008434 · NIDDK · YALE UNIVERSITY · PI KENNEDY, SCOTT P · 1989 to 1991
–
STRUCTURE AND FUNCTION OF THE RENAL EPITHELIAL CELL MEMBRANE SKELETONP01DK038979 · NIDDK · YALE UNIVERSITY · PI KASHGARIAN, MICHAEL · 1987 to 1998
–
NHLBI NIH HHS R01-HL28560NIDDK NIH HHS F32-DK08434NIDDK NIH HHS P0I-DK38979
6 · The paper itself

Abstract

Ankyrin mediates the attachment of spectrin to transmembrane integral proteins in both erythroid and nonerythroid cells by binding to the beta-subunit of spectrin. Previous studies using enzymatic digestion, 2-nitro-5-thiocyanobenzoic acid cleavage, and rotary shadowing techniques have placed the spectrin-ankyrin binding site in the COOH-terminal third of beta-spectrin, but the precise site is not known. We have used a glutathione S-transferase prokaryotic expression system to prepare recombinant erythroid and nonerythroid beta-spectrin from cDNA encoding approximately the carboxy-terminal half of these proteins. Recombinant spectrin competed on an equimolar basis with 125I-labeled native spectrin for binding to erythrocyte membrane vesicles (IOVs), and also bound ankyrin in vitro as measured by sedimentation velocity experiments. Although full length beta-spectrin could inhibit all spectrin binding to IOVs, recombinant beta-spectrin encompassing the complete ankyrin binding domain but lacking the amino-terminal half of the molecule failed to inhibit about 25% of the binding capacity of the IOVs, suggesting that the ankyrin-independent spectrin membrane binding site must lie in the amino-terminal half of beta-spectrin. A nested set of shortened recombinants was generated by nuclease digestion of beta-spectrin cDNAs from ankyrin binding constructs. These defined the ankyrin binding domain as encompassing the 15th repeat unit in both erythroid and nonerythroid beta-spectrin, amino acid residues 1,768-1,898 in erythroid beta-spectrin. The ankyrin binding repeat unit is atypical in that it lacks the conserved tryptophan at position 45 (1,811) within the repeat and contains a nonhomologous 43 residue segment in the terminal third of the repeat. It also appears that the first 30 residues of this repeat, which are highly conserved between the erythroid and nonerythroid beta-spectrins, are critical for ankyrin binding activity. We hypothesize that ankyrin binds directly to the nonhomologous segment in the 15th repeat unit of both erythroid and nonerythroid beta-spectrin, but that this sequence must be presented in the context of a properly folded spectrin "repeat unit" structure. Future studies will identify which residues within the repeat unit are essential for activity, and which residues determine the specificity of various spectrins for different forms of ankyrin.

Indexed as

Amino Acid SequenceAnkyrinsBinding SitesBlood ProteinsDNA Mutational AnalysisEscherichia coliHumansIn Vitro TechniquesMembrane ProteinsMolecular Sequence DataMolecular StructureProtein BindingRecombinant Fusion ProteinsSequence AlignmentSpectrinStructure-Activity RelationshipAnkyrinsBlood ProteinsMembrane ProteinsRecombinant Fusion ProteinsSpectrin

Identifiers

PMID1833409
PMCPMC2289929
OpenAlexW1964796114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.